 | • レポートコード：B-MOR-05320 • 出版社/出版日：Mordor Intelligence / 2018年4月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、小児介入性（インターベンション）心臓病学の世界市場について調べ、小児介入性（インターベンション）心臓病学の世界規模、市場動向、市場環境、製品タイプ別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・小児介入性（インターベンション）心臓病学の世界市場インサイト ・小児介入性（インターベンション）心臓病学の世界市場環境 ・小児介入性（インターベンション）心臓病学の世界市場動向 ・小児介入性（インターベンション）心臓病学の世界市場規模 ・小児介入性（インターベンション）心臓病学の世界市場規模：製品タイプ別 ・小児介入性（インターベンション）心臓病学の世界市場：地域別市場規模・分析 ・小児介入性（インターベンション）心臓病学の北米市場規模・予測 ・小児介入性（インターベンション）心臓病学のアメリカ市場規模・予測 ・小児介入性（インターベンション）心臓病学のヨーロッパ市場規模・予測 ・小児介入性（インターベンション）心臓病学のアジア市場規模・予測 ・小児介入性（インターベンション）心臓病学の日本市場規模・予測 ・小児介入性（インターベンション）心臓病学の中国市場規模・予測 ・小児介入性（インターベンション）心臓病学のインド市場規模・予測 ・小児介入性（インターベンション）心臓病学の韓国市場規模・予測 ・関連企業情報・競争状況 |
The Pediatric Interventional Cardiology Market is expected to grow at a CAGR of 6.5%. The market is growing at a significant rate, due to the increasing instances of heart diseases in children and the rising technological advancements in the field.
Rapid Technological Advances to Boost the Market
During the last 10 years, there have been various technological advancements in the pediatric interventional cardiology market. Some of the new advancements in cardiac imaging modalities, such as intracardiac echocardiography (ICE), real-time 3-dimensional (3D), transesophageal echocardiography (TEE), cardiac computed tomography (CT), magnetic resonance imaging (MRI), holography, 3D printing, etc. These technological advances can treat congenital heart diseases. Therapies like percutaneous pulmonic valve implantation, have achieved success in the market. The recent advancement of percutaneous pulmonary valve implantations, has helped reduce the risk and stress of open-heart surgery. Hence, due to these continuous technological advances, the market is growing at a faster pace.
Other factors driving the market include increasing awareness among the population, increased preference of minimally invasive procedures over conventional surgeries, and the rising number of the congenital disorders.
Different Regulatory Policies Delaying the Product Launches
According to the FDA product classification, majority of the medical devices used in pediatric interventional cardiology belong to the class III medical devices. The class III devices are considered to be of high risk devices and are subjected to strict regulations to be certified as safe and effective. Due to a number of regulations, the process required for the approval to distribute the new products is complex, expensive, and time-consuming, which causes a delay in the product launches. Hence, due to stringent regulatory policies, the market growth is hampered.
Other factors restraining the market include expensive treatments, therapies, and unfavorable market conditions for new players.
North America holds the Largest Share of the Market
The US pediatric interventional cardiology market has the largest share among the North American countries, which can be due to the rising number of the congenital heart defects. The Asia-Pacific region is also projected to grow at a significant rate during the next 7 years, due to the growing government investments in cardiology and medical tourism.
Key Developments in the Market
• March 2017: Boston Scientific announced that it had signed a definitive agreement to obtain Symetis SA, a manufacturer of transcatheter aortic valve replacement systems.
Major Players: ABBOTT, BOSTON SCIENTIFIC CORPORATION, CARDINAL HEALTH, EDWARDS LIFESCIENCES CORPORATION, GE HEALTHCARE, GORE MEDICAL, MEDTRONIC, NUMED INC., AND SIEMENS HEALTHCARE, amongst others.
Reasons to Purchase this Report
• Current and future global Pediatric Interventional Cardiology Market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment expected to dominate the market
• The region expected to witness the fastest growth rate during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rapid Technological Advances to Boost the Market Growth
6.1.2 Increasing Awareness in the Population
6.1.3 Increased Preference of Minimally Invasive Procedures over Conventional Surgeries
6.1.4 Increasing Congenital Disorders
6.2 Market Restraints
6.2.1 Different Regulatory Policies Delaying Product Launches
6.2.2 Expensive Treatment and Therapies
6.2.3 Unfavorable Market Conditions for New Players
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Closure Devices
7.1.1.1 Atrial Septal Defect (ASD) Closure Devices
7.1.1.2 Patent Ductus Arteriosis (PDA) Closure Devices
7.1.1.3 Ventrical Septal Defect (VSD) Closure Devices
7.1.1.4 Patent Foreman Ovale (PFO) Closure Devices
7.1.2 Transcatheter Heart Valves
7.1.3 Atherectomy Devices
7.1.4 Catheters
7.1.5 Guidewires
7.1.6 Balloons
7.1.7 Stents
7.1.8 Imaging Technique
7.1.8.1 Intravascular Ultrasound (IVUS)
7.1.8.2 Optical Coherence Tomography (OCT) Imaging
7.1.8.3 Near Infrared Spectroscopy (NIRS)
7.1.9 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott
9.2 Boston Scientific Corporation
9.3 Cardinal Health
9.4 Edwards Lifesciences Corporation
9.5 GE Healthcare
9.6 Gore Medical
9.7 Medtronic
9.8 NuMED Inc.
9.9 Siemens Healthcare
9.10 List Not Exhaustive
10. Future of the Market